13-15mg/kg/d ursodeoxycholic (DrugBank: -)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
93 | Primary biliary cholangitis [Primary biliary cirrhosis (~Mar 2017)] | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT03345589 (ClinicalTrials.gov) | January 30, 2018 | 6/11/2017 | A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis | A Randomized Controlled Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis | Primary Biliary Cholangitis | Drug: 18-22mg/kg/d Ursodeoxycholic;Drug: 13-15mg/kg/d Ursodeoxycholic | West China Hospital | NULL | Unknown status | 18 Years | 70 Years | All | 40 | Phase 4 | China |